ClassID:

21028

A61K38/47 - page 7 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Recent Application in this class:
#1801
20100322872
2010-12-23

NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS

#1802
20100316620
2010-12-16

Formulation and Method for the Prevention and Treatment of Skeletal Manifestation of Gaucher's Disease

#1803
20100310545
2010-12-09

Dry treatment mixture and methods of production and use

#1804
20100305500
2010-12-02

HYALURONIDASE AS AN ADJUVANT FOR INCREASING THE INJECTION VOLUME AND DISPERSION OF LARGE DIAMETER SYNTHETIC MEMBRANE VESICLES CONTAINING A THERAPEUTIC AGENT

#1805
20100303797
2010-12-02

Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes

#1806
20100291060
2010-11-18

SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE A

#1807
20100291059
2010-11-18

Proteins having acquired A-galactosidase activity

#1808
20100285080
2010-11-11

Cosmetic treatment system and methods

#1809
20100285028
2010-11-11

Methods of treating coagulopathy

#1810
20100278805
2010-11-04

Compositions for inhibiting atherosclerosis

#1811
20100270183
2010-10-28

Stable digestive enzyme compositions

#1812
20100268336
2010-10-21

Materials and Method for Promotion of Nerve Regeneration

#1813
20100260857
2010-10-14

Enzyme delivery systems and methods of preparation and use

#1814
20100255111
2010-10-07

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells

#1815
20100254966
2010-10-07

TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II

#1816
20100254949
2010-10-07

Prebiotic oligosaccharides

#1817
20100249746
2010-09-30

Drug delivery system for accelerated subcutaneous absorption

#1818
20100233218
2010-09-16

COMBINATION ENZYME FOR CYSTIC FIBROSIS

#1819
20100226908
2010-09-09

Compositions for promoting wound healing and treating psoriasis

#1820
20100211015
2010-08-19

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#1821
20100209502
2010-08-19

Treatments Which Alleviate Functional Glycosylated Leptin Transport Factor for Controlling Weight and Obesity

#1822
20100209411
2010-08-19

USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS

#1823
20100204448
2010-08-12

Method and carrier complexes for delivering molecules to cells

#1824
20100204447
2010-08-12

Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis

#1825
20100203528
2010-08-12

System for obfuscating identity

#1826
20100203138
2010-08-12

Controlled release composition comprising a recombinant gelatin

#1827
20100196423
2010-08-05

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#1828
20100196401
2010-08-05

USE OF RAPAMYCIN TO INHIBIT IMMUNE RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS

#1829
20100196344
2010-08-05

COMPOSITIONS AND METHODS FOR TREATING PANCREATIC INSUFFICIENCY

#1830
20100184845
2010-07-22

Myeloid Colony Stimulating Factor and Uses Thereof

#1831
20100184665
2010-07-22

Method for screening a test substance for activating a receptor associated with FGF 21 activity

#1832
20100183577
2010-07-22

Enzyme replacement therapy for treating lysosomal storage diseases

#1833
20100173979
2010-07-08

Gene therapy for lysosomal storage diseases

#1834
20100173385
2010-07-08

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof

#1835
20100172892
2010-07-08

Hyaluronidase and method of use thereof

#1836
20100167327
2010-07-01

System for obfuscating identity

#1837
20100166874
2010-07-01

Technology for Preparation of Macromolecular Microspheres

#1838
20100166701
2010-07-01

METHOD FOR TREATING RENAL CELL CARCINOMA USING GLYCOGENOLYSIS INHIBITORS

#1839
20100158808
2010-06-24

Altered Activity of Toll-Like Receptors

#1840
20100150897
2010-06-17

Compositions and methods for enzymatic treatment of lung disorders

#1841
20100144625
2010-06-10

Organic Compounds

#1842
20100144008
2010-06-10

TREATMENT OF FABRY DISEASE

#1843
20100143297
2010-06-10

METHODS OF ENHANCING LYSOSOMAL STORAGE DISEASE THERAPY BY MODULATION OF CELL SURFACE RECEPTOR DENSITY

#1844
20100135981
2010-06-03

Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases

#1845
20100135919
2010-06-03

Proteolytic enzyme formulations

#1846
20100129367
2010-05-27

Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such

#1847
20100124586
2010-05-20

STABLE, DURABLE GRANULES WITH ACTIVE AGENTS

#1848
20100119502
2010-05-13

THERAPY REGIMENS, DOSING REGIMENS AND STABLE MEDICAMENTS FOR THE TREATMENT OF POMPE DISEASE

#1849
20100119494
2010-05-13

METHODS AND COMPOSITIONS RELATED TO MODULATING THE EXTRACELLULAR STEM CELL ENVIRONMENT

#1850
20100113517
2010-05-06

METHOD FOR THE TREATMENT OF FABRY DISEASE USING PHARMACOLOGICAL CHAPERONES

#1851
20100111920
2010-05-06

METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES EMPLOYING PEROXIDE-PRODUCING ENZYMES AND PEROXIDASES

#1852
20100105870
2010-04-29

Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins Thereof

#1853
20100104549
2010-04-29

Treatment of cancer with glufosfamide in patients not receiving insulin therapy

#1854
20100104535
2010-04-29

Methods of treating anemia using recombinant adeno-associated virus virions

#1855
20100098767
2010-04-22

Convection enhanced delivery apparatus, method, and application

#1856
20100092450
2010-04-15

Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency

#1857
20100092449
2010-04-15

Treatment of Pompe's Disease

#1858
20100092447
2010-04-15

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES

#1859
20100080845
2010-04-01

Cosmetic Methods And Compositions For Repairing Human Skin

#1860
20100080787
2010-04-01

COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN ENZYME WHICH IS INSOLUBLE IN AN AQUEOUS MEDIUM AS WELL AS ITS USES

#1861
20100075906
2010-03-25

Targeted therapeutic proteins

#1862
20100074959
2010-03-25

Lipid microparticle growth factor formulations

#1863
20100061971
2010-03-11

Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method

#1864
20100056424
2010-03-04

Cosmetic use of chitinase-type proteins

#1865
20100055081
2010-03-04

Long-lasting absorption of flavonoids

#1866
20100048456
2010-02-25

Glycopegylation methods and proteins/peptides produced by the methods

#1867
20100047225
2010-02-25

Oligosaccharides comprising an aminooxy group and conjugates thereof

#1868
20100041606
2010-02-18

Methods of Use of Eggshell Polypeptides

#1869
20100041151
2010-02-18

Compositions and methods for treating lysosomal storage disease

#1870
20100040592
2010-02-18

LIPASE-CONTAINING COMPOSITION AND METHODS OF USE THEREOF

#1871
20100034797
2010-02-11

Lipase variants for pharmaceutical use

#1872
20100029564
2010-02-04

Solubilized protein composition obtained from eggshell membrane

#1873
20100028322
2010-02-04

ANTIMETASTATIC EFFECT ON HUMAN CELL DISORDERS

#1874
20100021537
2010-01-28

Stable digestive enzyme compositions

#1875
20100021505
2010-01-28

Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients

#1876
20100021450
2010-01-28

Lys K endolysin is synergistic with lysostaphin against MRSA

#1877
20100021430
2010-01-28

Horse feed and treatment methods

#1878
20100021416
2010-01-28

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

#1879
20100015698
2010-01-21

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

#1880
20100008897
2010-01-14

COMPOSITION FOR PROVIDING A BENEFIT TO A KERATIN-CONTAINING SUBSTRATE

#1881
20100004321
2010-01-07

Recombinant Staphylococcal Phage Lysin as an Antibacterial Agent

#1882
20100004170
2010-01-07

PROTEIN-CONTAINING SUBSTANCE WITH INCREASED THERMAL STABILITY

#1883
20100003238
2010-01-07

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

#1884
20100003235
2010-01-07

ORAL FORMULATIONS FOR ENTERIC DISORDERS AND/OR REHYDRATION

#1885
20090324730
2009-12-31

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME

#1886
20090324647
2009-12-31

Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use

#1887
20090324572
2009-12-31

Methods and compositions for the treatment of symptoms of Williams Syndrome

#1888
20090317484
2009-12-24

Salivary substitute

#1889
20090317378
2009-12-24

Antimicrobial composition and uses thereof

#1890
20090317371
2009-12-24

Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases

#1891
20090317364
2009-12-24

NOVEL COMPOSITIONS FOR PREVENTION AND TREATMENT OF MASTITIS AND METRITIS

#1892
20090311237
2009-12-17

Combination therapy using a soluble hyaluronidase and a bisphosphonate

#1893
20090311236
2009-12-17

Therapeutic Peptide Compositions And Methods Of Making And Using Same

#1894
20090304665
2009-12-10

Super fast-acting insulin compositions

#1895
20090297592
2009-12-03

Lipid Vesicle Composition

#1896
20090286270
2009-11-19

Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy

#1897
20090285790
2009-11-19

Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders

#1898
20090274635
2009-11-05

Bactericide having selectivity to cariogenic bacterium, and a method for sterilization of cariogenic bacterium

#1899
20090263372
2009-10-22

Method for the treatment of the symptoms of drug and alcohol addiction

#1900
20090263371
2009-10-22

Use polysaccharides for promotion of enzymatic activity

#1901
20090257989
2009-10-15

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells

#1902
20090253175
2009-10-08

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

#1903
20090252827
2009-10-08

Horse feed and methods of treating horses

#1904
20090252719
2009-10-08

Use of fructanases in feed of hoofed animals, preferably to prevent diseases

#1905
20090246187
2009-10-01

PROCESS FOR CONCENTRATION OF A POLYPEPTIDE

#1906
20090238802
2009-09-24

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells

#1907
20090232853
2009-09-17

TREATMENT OF LAMINITIS

#1908
20090232789
2009-09-17

Compositions and use thereof for treating symptoms of preeclampsia

#1909
20090226414
2009-09-10

Method for detecting infectious parvovirus in pharmaceutical preparations

#1910
20090220588
2009-09-03

Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity

#1911
20090214660
2009-08-27

ENCAPSULATION SYSTEM

#1912
20090214636
2009-08-27

Imaging and Therapeutic Method Using Monocytes

#1913
20090214511
2009-08-27

DIGESTIBLE COMPOSITIONS OF INULIN FOR MANAGING BLOOD GLUCOSE LEVELS

#1914
20090214505
2009-08-27

Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)

#1915
20090208477
2009-08-20

Production of high mannose proteins in plant culture and therapeutic uses thereof

#1916
20090208459
2009-08-20

Methods of treating anemia using recombinant adeno-associated virus virions

#1917
20090203575
2009-08-13

TARGETED THERAPEUTIC PROTEINS

#1918
20090202516
2009-08-13

INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS

#1919
20090202481
2009-08-13

Composition for Sustained Release Delivery of Proteins or Peptides

#1920
20090197289
2009-08-06

Method for identifying autistic individuals amenable to digestive enzyme therapy

#1921
20090196858
2009-08-06

AMELIORATING AGENT FOR BRAIN DAMAGE

#1922
20090181032
2009-07-16

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

#1923
20090181013
2009-07-16

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

#1924
20090181000
2009-07-16

Method for increasing fructose digestion with strains of and fructase

#1925
20090169539
2009-07-02

PDGF fusion proteins incorporated into fibrin foams

#1926
20090163311
2009-06-25

Series spring blade tensioner

#1927
20090148432
2009-06-11

Compositions for inhibiting atherosclerosis

#1928
20090143436
2009-06-04

Anesthetic composition, formulation and method of use

#1929
20090142315
2009-06-04

Methods for increasing lactose and fructose digestion

#1930
20090136467
2009-05-28

APOLIPOPROTEIN ANALOGUES

#1931
20090130081
2009-05-21

Method for treating pervasive development disorders

#1932
20090130079
2009-05-21

Intraventricular enzyme delivery for lysosomal storage diseases

#1933
20090123367
2009-05-14

Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases

#1934
20090117117
2009-05-07

Targeting ABCB5 for cancer therapy

#1935
20090110698
2009-04-30

METHOD OF DETERMINING VACCINE COMPLIANCE

#1936
20090104173
2009-04-23

Process for solubilizing protein from a proteinaceous material and compositions thereof

#1937
20090098207
2009-04-16

Technology for the Preparation of Microparticles

#1938
20090092996
2009-04-09

Mucopolysaccharidosis (MPS) diagnostic methods, systems, kits and assays associated therewith

#1939
20090081300
2009-03-26

AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE

#1940
20090081184
2009-03-26

NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN

#1941
20090075960
2009-03-19

Method of treating gaucher disease

#1942
20090068167
2009-03-12

Compositions for promoting wound healing and treating psoriasis

#1943
20090068155
2009-03-12

Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system

#1944
20090062205
2009-03-05

Reconstitution medium for protein and peptide formulations

#1945
20090047309
2009-02-19

COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN

#1946
20090041743
2009-02-12

SPERM-BLOCKING AGENT COMPOSITION WITH CONTRACEPTIVE EFFECT

#1947
20090041740
2009-02-12

CANCER TREATMENT BY METABOLIC MODULATIONS

#1948
20090029467
2009-01-29

Method for targeting lysosomal enzymes

#1949
20090029005
2009-01-29

Anti-hypertensive functional food products

#1950
20090023893
2009-01-22

USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS

#1951
20090022727
2009-01-22

INJECTABLE, NONAQUEOUS SUSPENSION WITH HIGH CONCENTRATION OF THERAPEUTIC AGENT

#1952
20090017005
2009-01-15

Delivery of therapeutic compounds to the brain and other tissues

#1953
20090010913
2009-01-08

Natural liniment for treatment of skin cancers

#1954
20080317666
2008-12-25

Colonic Delivery of Active Agents

#1955
20080311192
2008-12-18

Enteric-Coated Glucosinolates And Beta-Thioglucosidases

#1956
20080305084
2008-12-11

Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions

#1957
20080299640
2008-12-04

Acid alpha-glucosidase and fragments thereof

#1958
20080299185
2008-12-04

Stable digestive enzyme compositions

#1959
20080286253
2008-11-20

Composition Comprising Polymeric Material And Uses Thereof

#1960
20080279953
2008-11-13

Methods of producing stable pancreatic enzyme compositions

#1961
20080279945
2008-11-13

GEL-BASED DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS

#1962
20080279839
2008-11-13

Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency

#1963
20080274174
2008-11-06

Stable pancreatic enzyme compositions

#1964
20080261909
2008-10-23

Gene Delivery to Organs

#1965
20080260708
2008-10-23

METHODS AND RELATED SYSTEMS AND FORMULATIONS TO NORMALIZE AND IMPROVE HUMAN BODY CHEMISTRY AND HEALING ABILITY

#1966
20080248127
2008-10-09

Standardized bee venom preparation

#1967
20080248021
2008-10-09

Use of Hyaluronidase in Combination with Plasmin for the Induction of Posterior Vitreous Detachment

#1968
20080233175
2008-09-25

Glucanases, nucleic acids encoding them and methods for making and using them

#1969
20080226658
2008-09-18

Targeting of glycoprotein therapeutics

#1970
20080226615
2008-09-18

Vectors having both isoforms of beta-hexosaminidase and uses of the same

#1971
20080219966
2008-09-11

Methods of treating pervasive development disorders

#1972
20080213320
2008-09-04

Compositions for treatment of gastro-esophageal reflux disorders

#1973
20080213242
2008-09-04

Composition and method for treating bovine papilloma virus in equine

#1974
20080213196
2008-09-04

Enzyme containing composition, process of producing said composition and its use

#1975
20080213188
2008-09-04

NOVEL OPHTHALMIC COMPOSITIONS CONTAINING HUMAN RECOMBINANT LYSOZYME AND USE THEREOF FOR TREATING EYE CONDITIONS AND AS CONTACT LENS SOLUTIONS

#1976
20080206223
2008-08-28

Treatment of Pompe's disease

#1977
20080206201
2008-08-28

Recombinant Newcastle Disease Virus

#1978
20080199453
2008-08-21

Botulinum toxin compositions and methods

#1979
20080199452
2008-08-21

Botulinum toxin compositions and methods

#1980
20080199448
2008-08-21

ENZYME COMPOSITION FOR IMPROVING FOOD DIGESTION

#1981
20080199442
2008-08-21

Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors

#1982
20080187525
2008-08-07

Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms

#1983
20080175833
2008-07-24

Treatment of glycogen storage disease type II

#1984
20080166334
2008-07-10

COMBINATION ENZYME FOR CYSTIC FIBROSIS

#1985
20080152637
2008-06-26

Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders

#1986
20080145355
2008-06-19

Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes

#1987
20080127350
2008-05-29

System for obfuscating identity

#1988
20080124316
2008-05-29

USE OF HYALURONIDASE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

#1989
20080124315
2008-05-29

Method of reducing CRF receptor mRNA

#1990
20080118491
2008-05-22

Xylanase gene sequences from the genomic DNA of unpurified rumen microorganisms

#1991
20080112942
2008-05-15

Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption

#1992
20080112917
2008-05-15

Sphingolipids' polyalkylamines conjugates

#1993
20080096808
2008-04-24

USE OF RAPAMYCIN TO INHIBIT RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS

#1994
20080075708
2008-03-27

Broad specturm anti-viral therapeutics and prophylaxis

#1995
20080069803
2008-03-20

Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors

#1996
20080051355
2008-02-28

System for obfuscating identity

#1997
20080047551
2008-02-28

System for obfuscating identity

#1998
20080038240
2008-02-14

Methods for increasing lactose digestion

#1999
20080038232
2008-02-14

Human lysosomal proteins from plant cell culture

#2000
20080031868
2008-02-07

HUMAN LYSOZYME MEDICINE, ITS MANUFACTURING METHOD AND APPLICATION THEREOF

#2001
20080031866
2008-02-07

METHOD FOR MODULATING THE PHARMACOKINETICS AND METABOLISM OF A THERAPEUTIC AGENT

#2002
20080025963
2008-01-31

Compositions and methods for the treatment of CNS injuries

#2003
20080020036
2008-01-24

Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers

#2004
20080020016
2008-01-24

Pharmaceutical compositions for sustained release delivery of peptides

#2005
20080014623
2008-01-17

Nutrient absorption enhancing compositions and methods

#2006
20080008694
2008-01-10

METHODS TO PREVENT AND TREAT DISEASES

#2007
20070292496
2007-12-20

Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics

#2008
20070286846
2007-12-13

Novel methods for ester detoxication

#2009
20070280925
2007-12-06

Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases

#2010
20070275085
2007-11-29

Compositions and methods for the cure of HIV / AIDS

#2011
20070274980
2007-11-29

Compositions of less immunogenic and long-circulating protein-lipid complexes

#2012
20070264273
2007-11-15

SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF

#2013
20070264247
2007-11-15

Use of Human Lysozyme in Preparation of Medicine for Treating Acne

#2014
20070258941
2007-11-08

Methods and compositions for remediation of disc herniation by modifying structure

#2015
20070254021
2007-11-01

Cosmetic treatment system and methods

#2016
20070253983
2007-11-01

Augmentation of titer for vaccination in animals

#2017
20070253941
2007-11-01

Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof

#2018
20070238693
2007-10-11

Genetic modification of the lung as a portal for gene delivery

#2019
20070231314
2007-10-04

Polypeptides and compositions derived from the horny layer of the epidermis and its use

#2020
20070224670
2007-09-27

Chondroitinase ABC I and methods of production

#2021
20070213382
2007-09-13

2-METHYLTHIAZOLIDINE-2, 4-DICARBOXYLIC ACID-CONTAINING COMBINATION PREPARATIONS

#2022
20070212340
2007-09-13

Use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses

#2023
20070207963
2007-09-06

USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS

#2024
20070202563
2007-08-30

Chondroitinase ABC I and methods of analyzing therewith

#2025
20070202092
2007-08-30

Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#2026
20070197439
2007-08-23

Stabilized compositions of proteins having a free thiol moiety

#2027
20070190163
2007-08-16

Technology for preparation of macromolecular microspheres

#2028
20070178081
2007-08-02

Combination therapy for treating protein deficiency disorders

#2029
20070166813
2007-07-19

Partially deglycosylated glucocerebrosidase polypeptide and crystals thereof

#2030
20070160593
2007-07-12

Sugar chain-cleaving agent

#2031
20070148740
2007-06-28

Chondroitinase ABC I and methods of degrading therewith

#2032
20070148158
2007-06-28

Rationally designed heparinases derived from heparinase II

#2033
20070148157
2007-06-28

Chondroitinase ABC I polynucleotides

#2034
20070148156
2007-06-28

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

#2035
20070148153
2007-06-28

Delayed release pancreatin compositions

#2036
20070148152
2007-06-28

Process for the manufacture and use of pancreatin micropellet cores

#2037
20070141059
2007-06-21

Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic

#2038
20070141041
2007-06-21

Enzymes for reduced immunological stress

#2039
20070137657
2007-06-21

Ophthalmic surgical irrigating solutions containing hyaluronidase and method for preventing post-operative intraocular pressure increases

#2040
20070122450
2007-05-31

Treatment of ophthalmic conditions

#2041
20070116698
2007-05-24

Novel methods and medicament for treating infectious diseases involving microbial biofilms

#2042
20070116695
2007-05-24

PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS

#2043
20070099824
2007-05-03

Treatments which Alleviate Functional Glycosylated Leptin Transport Factor, for Controlling Weight and Obesity

#2044
20070086993
2007-04-19

USE OF MODIFIED LYSOZYME C TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES

#2045
20070081985
2007-04-12

Lysozyme fortified milk and milk products

#2046
20070081952
2007-04-12

Composition for the treatment of bad breath

#2047
20070077273
2007-04-05

Microfabricated nanopore device for sustained release of therapeutic agent

#2048
20070053895
2007-03-08

METHOD OF TREATING AND DIAGNOSING PARKINSONS DISEASE AND RELATED DYSAUTONOMIC DISORDERS

#2049
20070053870
2007-03-08

Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof

#2050
20070031945
2007-02-08

High mannose proteins and methods of making high mannose proteins

#2051
20070031397
2007-02-08

Compositions and methods for enhancing axon regeneration

#2052
20070026485
2007-02-01

Glycopegylation methods and proteins/peptides produced by the methods

#2053
20070025978
2007-02-01

Bacteriophage lysins for and other bacteria

#2054
20070020249
2007-01-25

COMPOSITIONS FOR PREVENTION AND TREATEMENT OF SYMPTOMS OF GASTROINTESTINAL DISTRESS

#2055
20070020243
2007-01-25

Methods and compositions related to modulating the extracellular stem cell environment

#2056
20070011754
2007-01-11

Lysosomal proteins produced in the milk of transgenic animals

#2057
20070009505
2007-01-11

Composition and system for wound decontamination

#2058
20070009434
2007-01-11

Imaging and therapeutic method using monocytes

#2059
20060292205
2006-12-28

Substitute for animal protein in cattle feed

#2060
20060286087
2006-12-21

Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof

#2061
20060275902
2006-12-07

Cell and virus catabolism

#2062
20060270007
2006-11-30

Method for producing glucoamylases and their uses

#2063
20060269535
2006-11-30

Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy

#2064
20060264467
2006-11-23

Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives

#2065
20060252718
2006-11-09

Sphingolipids polyalkylamine conjugates for use in transfection

#2066
20060252717
2006-11-09

Sphingoid polyalkylamine conjugates for vaccination

#2067
20060251641
2006-11-09

Method and apparatus for treatment of cardiac disorders

#2068
20060247201
2006-11-02

Myeloid colony stimulating factor and uses thereof

#2069
20060239992
2006-10-26

Methods and compositions for the inhibition of growth of infectious and other mycotic organisms in the gut of mammalian and avian species

#2070
20060229247
2006-10-12

T. cruzi-derived neurotrophic agents and methods of use therefor

#2071
20060228348
2006-10-12

Targeting of glycoprotein therapeutics

#2072
20060198838
2006-09-07

Combination enzyme for cystic fibrosis

#2073
20060193845
2006-08-31

Combination therapy for controlled carbohydrate digestion

#2074
20060183180
2006-08-17

Methods for treating pervasive development disorders

#2075
20060182728
2006-08-17

Methods for treating pervasive development disorders

#2076
20060177433
2006-08-10

Treatment of α-galactosidase A deficiency

#2077
20060159671
2006-07-20

Uses of sysnergistic bacteriophage lytic enzymes for prevention and treatment of bacterial infections

#2078
20060153829
2006-07-13

Stable formulations of purified proteins

#2079
20060128587
2006-06-15

Lipase-containing composition and methods of use thereof

#2080
20060127484
2006-06-15

Controlled release composition

#2081
20060121019
2006-06-08

Compositions for treating cystic fibrosis

#2082
20060121017
2006-06-08

Compositions and methods for treating pancreatic insufficiency

#2083
20060121011
2006-06-08

Combination gene delivery vehicles

#2084
20060115468
2006-06-01

Dietary supplement for treating and preventing gastrointestinal disorders

#2085
20060115436
2006-06-01

Enzyme containing composition, process of producing said composition and its use

#2086
20060105430
2006-05-18

Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewith

#2087
20060104968
2006-05-18

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases

#2088
20060100135
2006-05-11

Compositions and methods for modifying toxic effects of proteinaceous compounds

#2089
20060099185
2006-05-11

Methods of treating anemia using recombinant adeno-associated virus virions

#2090
20060099184
2006-05-11

Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors

#2091
20060094684
2006-05-04

Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products

#2092
20060089297
2006-04-27

Sperm specific lysozyme-like proteins

#2093
20060083737
2006-04-20

Methods of intracellular peptide delivery

#2094
20060083732
2006-04-20

Hyaluronic acid in the enhancement of lens regeneration

#2095
20060083731
2006-04-20

Use of an enzyme for the manufacture of an agent for controlling bacterial infection

#2096
20060078959
2006-04-13

Recombinant chondroitinase ABC I and uses thereof

#2097
20060078542
2006-04-13

Gel-based delivery of recombinant adeno-associated virus vectors

#2098
20060057133
2006-03-16

Topical pathogenic-tissue-destroying liquid

#2099
20060045874
2006-03-02

Aminoglycoside treatment for lysosomal storage diseases

#2100
20060034824
2006-02-16

Pharmaceutical composition comprising carriers for products